Table Of Content

Author index Clements M.R., Davies M., Hayes M.E., Hickey C.D., Faber J. see Jarlov E.A. Lumb G.A., Mawer E.B. & Adams P.H. The role of Fadini R. see Webster J. 1,25-dihydroxyvitamin D in the mechanism of Faglia G. see Webster J. acquired vitamin D deficiency 17 Fairclough P.D. see Anderson J.V. Cohn M. see Price A. Falsetti L. see Webster J. Colin E. see Gallardo E. Farmery M.R. see Thakker R.V. Colman P.G. see Leedman P.J. Fauser B.C.J.M., Pache T.D., Hop W.C.J., de Jong F.H. Colwell A. see Hassager C. & Dahl K.D. The significance ofa single serum LH Compston J.E., Bhambani M., Laskey M.A., Murphy S. measurement in women with cycle disturbances: & Khaw K.T. Body composition and bone mass in discrepancies between immunoreactive and bioactive post-menopausal women 426 hormone estimates 445 Conway G.S., Agrawal R., Betteridge D.J. & Jacobs H.S. Ferrari C. see Webster J. Risk factors for coronary artery disease in lean and Fioretti P. see Webster J. obese women with the polycystic ovary syndrome 119 Flamigni F. see Webster J. Cosby H. see Leite V. Fletcher J.A. see Jenkins D. Cotterill A-M. Commentary The therapeutic potential of Fontoura M., Mugnier F., Brauner R., Rappaport R. & recombinant human insulin-like growth factor-I 11 Postel-Vinay M-C. Effect of growth hormone on the Crosignani P.G. see Webster J. low level of growth hormone binding protein in Cross K.W. see Parle J.V. idiopathic short stature 249 Cuckle H.S. see Kennedy R.L. Forest J-C. see Brideau N-A. Curto L. see Cannavo S. Forti G. see Genazzani A.D. Franklyn J.A. see Jenkins D. Franklyn J.A. see Parle J.V. D’Alberton A. see Webster J. Franklyn J.A. see Sheppard M.C. Dahl K.D. see Fauser B.C.J.M. Fraser R. see Walker B.R. Darne J. see Price A. Fraser W.D. see Wilson R. Davidson K. see Price D.E. Frauman A.G. see Leedman P.J. Davies M. see Clements M.R. Fresnoza A. see Leite V. Davies R. see Price A. Friesen H.G. see Leite V. Davila D.G. see O’Brien T. Funder J. Commentary ACTH, cortisol and 116-OHSD: Davoli S. see Valcavi R. Quis custodet custodes? 481 De Carli M. see Mariotti S. De Cecco L. see Webster J. Gallardo E., Schachter D., Caceres E., Becker P., de Jong F.H. see Fauser B.C.J.M. Colin E., Martinez C. & Henriquez C. The empty De Natale R. see Cannavo S. sella: results of treatment in 76 successive cases and Del Prete G.F. see Mariotti S. high frequency endocrine and neurological Di Silvio L. see Pringle P.J. disturbances 529 Dodin S. see Brideau N-A. Garcia-Rubi E., Vazquez-Aleman D., Mendez J.P., Doniach I. Commentary Pituitary carcinoma 194 Salinas J.L., Garza-Flores J., Ponce-de Leon S.., Donker G.H. see Roelen C.A.M. Perez-Palacios G. & Ulloa-Aguirre A. The effects of Dons R.F. see Rone J.K. opioid blockade and GnRH administration upon Dryburgh F. see Wilson R. luteinizing hormone secretion in patients with Dyer S. see Clayton R.N. anorexia nervosa during the stages of weight loss and weight recovery 520 Eastell R. see Hassager C. Garza-Flores J. see Garcia-Rubi E. Edhag O.K. see Rosenqvist M. Genazzani A.D., Forti G., Guardabasso V., Maggi M.., Edwards C.R.W. see Walker B.R. Milloni M., Cianfanelli F. & Serio M. Frequency of Eldred J.M., Haynes P.J. & Thomas E.J. A randomized prolactin pulsatile release in normal men and in double blind placebo controlled trial of the effects on agonadal patients is neither coupled to LH release nor bone metabolism of the combination of nafarelin influenced by androgen modulation 65 acetate and norethisterone 354 Giannou P. see Tsagarakis S. Endert E. see Adriaanse R. Giordano G. see Webster J. Evans M.C. see Reid I.R. Goldray D. see Matzkin H. 578 Author index Gétzmann J. see Blind E. Hindmarsh P.C. see Pringle P.J. Graf S. see Herfarth K. Ho P.M.W. see Grill V. Graham C.T. see Stewart P.M. Hodgkinson J. see Clayton R.N. Grant P.J. see Orme S.M. Hofland L.J., Van der Lely A.J., Van Koetsveld P.M., Gray C. see Harvey J.N. Kazemzadeh M., Waaijers M., Hooghe-Peters E.L. & Gray C. see Wilson R. Lamberts S.W.J. Long-term in-vitro treatment of Gray H.W. see Quin J.D. human growth hormone (GH)-secreting pituitary Greene S.A. see Gregory J.W. adenoma cells with octreotide causes accumulation of Gregory J.W., Greene S.A., Thompson J., Scrimgeour C.M. intracellular GH and GH mRNA levels 240 & Rennie M.J. Effects of oral testosterone Hoick S. see Kruse A. undecanoate on growth, body composition, strength Hoogerbrugge N. see Binnerts A. and energy expenditure of adolescent boys 207 Hooghe-Peters E.L. see Hofland L.J. Griffiths H. see Price A. Hop W.C.J. see Fauser B.C.J.M. Grill V., Hillary J., Ho P.M.W., Law F.M.K., Maclsaac Horvath E. see O’Brien T. R.J., Moseley J.M., MaclIsaac I.A. & Martin T.J. Howlett T.A. see Price D.E. Parathyroid hormone-related protein: a possible Hunter P. see Baxter M.A. endocrine function in lactation 405 Grossman A. see Tsagarakis S. Ishikawa E. see Tamaki H. Guardabasso V. see Genazzani A.D. Ginther T. see Riedel M. Jaccard N. see Matzkin H. Guthrie C. see Leese G.P. Jacobs H.S. see Conway G.S. Jacobs K.H. see Jenkins D. Hansen J.M. see Jarlov E.A. Jarlov E.A., Faber J., Hegediis L. & Hansen J.M. Subtle Harris A.G. see Van der Lely A.J. changes in serum thyrotrophin (TSH) and sex- Harvey J.N. & Barnett D. Case report and review hormone-binding globulin (SHBG) levels during long- Endocrine dysfunction in Kearns-Sayre syndrome 97 term follow-up after radioactive iodine in Harvey J.N., Gray C. & Belchetz P.E. Case of the Month multinodular non-toxic goitre 335 Oncogenous osteomalacia and malignancy 379 Jenkins D., Penny M.A., Fletcher J.A., Jacobs K.H., Hassager C., Colwell A., Assiri A.M.A., Eastell R., Mijovic C.H., Franklyn J.A. & Sheppard M.C. HLA Russell R.G.G. & Christiansen C. Effect of class II gene polymorphism contributes little to menopause and hormone replacement therapy on Hashimoto’s thyroiditis 14] urinary excretion of pyridinium cross-links: a Jones J. see Miell J.P. longitudinal and cross-sectional study 45 Jones S.R. see Parle J.V. Hayes M.E. see Clements M.R. Jones T.H. see Kennedy R.L. Haynes P.J. see Eldred J.M. Jung R.T. see Leese G.P. Hegediis L. see Jarlov E.A. Hendricks M.S. see Lindow S.W. Karmali R. see Hewison M. Henriquez C. see Gallardo E. Kasmayr J. see Wehling M. Herfarth K., Schmidt-Gayk H., Graf S. & Maier A. Katsumaru H. see Tamaki H. Circadian rhythm and pulsatility of parathyroid Kautzky-Willer A., Pacini G., Niederle B., Schernthaner G. hormone secretion in man 511 & Prager R. Insulin secretion, insulin sensitivity and Heufelder A.E., Bahn R.S. & Smith T.J. Regulation by hepatic insulin extraction in primary glucocorticoids of interferon gamma-induced HLA- hyperparathyroidism before and after surgery 147 DR antigen expression in cultured human orbital Kazemzadeh M. see Hofland L.J. fibroblasts 59 Kennedy L. see Price A. Hewison M., Karmali R. & O’Riordan J.L.H. Kennedy R.L., Jones T.H. & Cuckle H.S. Review Down’s Commentary Tumour induced osteomalacia 382 syndrome and the thyroid 471 Hickey C.D. see Clements M.R. Kerlan V., Nahoul K., Abalain J-H., Mangin P. & Hillary J. see Grill V. Bercovici J-P. Oestrogen secreting Leydig cell tumour Hillier S.G. see Yong E.L. and GnRH agonist in-vivo and in-vitro studies 221 Hiltner A.N. see Moreira A.C. Khaw K.T. see Compston J.E. Hindmarsh P. Commentary Oestrogen therapy for girls Klinkin L. see Kruse A. with tall stature 199 Kohl B. see Blind E. Author index 579 Kontogeorgos G. see Tsagarakis S. London D.R. see Stewart P.M. Koper J.W. see Lamberts S.W.J. Lowe D.G. see Anderson J.V. Koppeschaar H.P.F. see Roelen C.A.M. Lumb G.A. see Clements M.R. Kovacs K. see O’Brien T. Kraiem Z., Cho B.Y., Sadeh O., Shong M.H., Pickerill P. Maciel L.M.Z. see Moreira A.C. & Weetman A.P. The IgG subclass distribution of Maclsaac I.A. see Grill V. TSH receptor blocking antibodies in primary Maclsaac R.J. see Grill V. hypothyroidism 135 MacLean M. see Wilson R. Krenning E.P. see Lamberts S.W.J. Maggi M. see Genazzani A.D. Kruse A., Klinkin L., Hoick S. & Lindholm J. Pituitary Maier A. see Herfarth K. histology in Cushing’s disease 254 Mangin P. see Kerlan V. Kurtz A.B. see Pringle P.J. Marino M. see Mariotti S. Mariotti S., Caturegli P., Barbesino G., Marind M., Del L’Hermite M. see Webster J. Prete G.F., Chiovato L., Tonacchera M., De Carli M. Lambert A. see Rodgers M. & Pinchera A. Thyroid function and thyroid Lamberts S.W.J. see Binnerts A. autoimmunity independently modulate serum Lamberts S.W.J. see Hofland L.J. concentration of soluble interleukin 2 (IL-2) receptor Lamberts S.W.J. see Van der Lely A.J. (sIL-2R) in thyroid diseases 415 Lamberts S.W.J., Koper J.W., Reubi J-C. & Krenning E.P. Marks V. Review Recognition and differential diagnosis of Review Endocrine aspects of the diagnosis and spontaneous hypoglycaemia 309 treatment of primary brain tumours | Martin T.J. see Grill V. Lamberts S.W.J., Valk N.K. & Binnerts A. Commentary Martinez C. see Gallardo E. The use of growth hormone in adults: a changing Massa G., Bouillon R. & Vanderschueren-Lodeweyckx M. scene I11 Serum levels of growth hormone-binding protein and Laskey M.A. see Compston J.E. insulin-like growth factor-I during puberty 175 Law F.M.K. see Grill V. Matthews D.R. see Pringle P.J. Leedman P.J., Frauman A.G., Colman P.G. & Matzkin H., Chen J., Weisman Y., Goldray D., Pappas F., Michelangeli V.P. Measurement of thyroid- Jaccard N. & Braf Z. Prolonged treatment with stimulating immunoglobulins by incorporation of finasteride (a Sx-reductase inhibitor) does not affect tritiated-adenine into intact FRTL-S cells: a viable bone density and metabolism 432 alternative to radioimmunoassay for the measurement Mawer E.B. see Clements M.R. of cAMP 493 McGauley G.A. & Sénksen P.H. Review The growth Leese G.P., Jung R.T., Guthrie C., Waugh N. & hormone deficiency syndrome in adults 387 Browning M.C.K. Morbidity in patients on McKeigue P. Commentary Are women with polycystic L-thyroxine: a comparison of those with a normal ovary syndrome at special risk for coronary heart TSH to those with a suppressed TSH 500 disease? 117 Leicester R. see Miell J.P. McKillop J.J. see Reglinski J. Leight G.S. see Schachter P.S. McKillop J.H. see Wilson R. Leite V., Cosby H., Sobrinho L.G., Fresnoza A.., McNair P. see Schwartz P. Santos M.A. & Friesen H.G. Characterization of big, Meade T.W. see Clayton R.N. big prolactin in patients with Mendez J.P. see Garcia-Rubi E. hyperprolactinaemia 365 Meunier P.J. see Bradbeer J.N. Lemay A. see Brideau N-A. Michelangeli V.P. see Leedman P.J. Leng G. see Lindow S.W. Miell J.P., Taylor A.M., Jones J., Buchanan C.R., Rennie J., Li Calzi L. see Cannavo S. Sherwood R., Leicester R. & Ross R.J.M. Lindholm J. see Kruse A. Administration of human recombinant insulin-like Lindow S.W., Van der Spuy Z.M., Hendricks M.S., growth factor-I to patients following major Rosselli A.P., Lombard C. & Leng G. The effect of gastrointestinal surgery 542 morphine and naloxone administration on plasma Mijovic C.H. see Jenkins D. oxytocin concentration in the first stage of labour Milloni M. see Genazzani A.D. 349 Milner R.D.G. see Thakker R.V. Lombard C. see Lindow S.W. Mitchell R. see Rodgers M. London D.R. see Baxter M.A. Miyai K. see Tamaki H. 580 Author index Momsen G. see Schwartz P. Pols H.A.P. see Binnerts A. Moreira A.C., Castro M., Maciel L.M.Z. & Hiltner A.N. Ponce-de Leon S. see Garcia-Rubi E. Luteinizing hormone response to clomiphene citrate Poole J. see Weetman A.P. in central precocious puberty 73 Portioli I. see Valcavi R. Morris I.D. see Buckler H.M. Postel-Vinay M-C. see Fontoura M. Moseley J.M. see Grill V. Prager R. see Kautzky-Willer A. Mudde A.H., Reijnders F.J.L. & Nieuwenhuijzen A.C. Prank K. see Adriaanse R. Peripheral bone density in women with untreated Price A., Griffiths H., Kennedy L., Darne J., Cohn M. & multinodular goitre 35 Davies R. Comparison of methods for the Mugnier E. see Fontoura M. determination of unbound triiodothyronine in Miiller O-A. see Wehling M. pregnancy 41 Mullis P.E. & Bricknell P.M. The use of the polymerase Price D.E., Absalom S.R., Davidson K., Bolia A., chain reaction in prenatal diagnosis of growth Bell P.R.F. & Howlett T.A. Case of the Month A hormone gene deletions 89 case of multiple endocrine neoplasia: Murphy S. see Compston J.E. hyperparathyroidism, insulinoma, GRF-oma, hypercalcitoninaemia and intractable peptic Nahoul K. see Kerlan V. ulceration 187 Najjar S.S. see Stanley J.M. Pringle P.J., Di Silvio L., Hindmarsh P.C., Matthews D.R.., Nakamoto H. see Tamaki H. Kurtz A.B. & Brook C.G.D. Analysis of trough Niederle B. see Kautzky-Willer A. serum growth hormone concentrations: comparison Nieuwenhuijzen Kruseman A.C. see Mudde A.H. of an immunoradiometric assay and a sensitive Nordenstrém J. see Rosenqvist M. ELISA for growth hormone 169 O’Brien T., Young W.F., Davila D.G., Scheithauer B.W.., Quin J.D., Gray H.W., Baxter J.N. & Thomson J.A. Case Kovacs K., Horvath E., Vale W. & Van Heerden J.A. of the Month Thyroid abscess complicating subacute Case of the Month Cushing’s syndrome associated thyroiditis: A consequence of steroid therapy? 570 with ectopic production of corticotrophin-releasing hormone, corticotrophin and vasopressin by a Rappaport R. see Fontoura M. phaeochromocytoma 460 Ratcliffe W.A. Commentary Role of parathyroid related O'Riordan J.L.H. see Hewison M. protein: a possible endocrine function in Ogden V. see Clayton R.N. lactation 405 Oldroyd B. see Orme S.M. Raue F. see Blind E. Orme S.M., Sebastian J.P., Oldroyd B., Stewart S.P., Reed H.L. see Rone J.K. Grant P.J., Stickland M.H., Smith M.A. & Reeve J. see Bradbeer J.N. Belchetz P.E. Comparison of measures of body Reglinski J., Smith W.E., Wilson R., Buchanan L.M.., composition in a trial of low dose growth hormone McKillop J.H. & Thomson J.A. Spin echo nuclear replacement therapy 453 magnetic resonance studies on intact erythrocytes: changes in cellular metabolism as a consequence of Pache T.D. see Fauser B.C.J.M. carbimazole therapy 319 Pacini G. see Kautzky-Willer A. Reid I.R., Wattie D.J., Evans M.C. & Budayr A.A. Case Padayachi T. see Saunders P.T.K. report and review Post-pregnancy osteoporosis Pappas F. see Matzkin H. associated wtih hypercalcaemia 298 Parle J.V., Franklyn J.A., Cross K.W., Jones S.R. & Reijnders F.J.L. see Mudde A.H. Sheppard M.C. Circulating lipids and minor Rennie J. see Miell J.P. abnormalities of thyroid function 411 Rennie M.J. see Gregory J.W. Paul Wilson J.H. see Binnerts A. Reubi J-C. see Lamberts S.W.J. Peers N. see Rodgers M. Riedel M., Giinther T., von zur Mihlen A. & Brabant G. Penny M.A. see Jenkins D. The pulsatile GH secretion in acromegaly: Perez-Palacios G. see Garcia-Rubi E. Hypothalamic or pituitary origin? 233 Pickerill P. see Kraiem Z. Rivarola M.A. see Belgorosky A. Pinchera A. see Mariotti S. Robertson W.R. see Buckler H.M. Piscitelli G. see Webster J. Robertson W.R. see Rodgers M. Polli A. see Webster J. Rodgers M., Mitchell R., Lambert A., Peers N. & Author index 581 Robertson W.R. Human chorionic gonadotrophin Sippell W. see Wehling M. contributes to the bioactivity of Pergonal 558 Smith M.A. see Orme S.M. Rodin D.A. see Clayton R.N. Smith T.J. see Heufelder A.E. Roel Swart G. see Binnerts A. Smith W.E. see Reglinski J. Roelen C.A.M., Donker G.H., Thijssen J.H.H., Sobrinho L.G. see Leite V. Koppeschaar H.P.F. & Blankenstein M.A. High Sonksen P.H. see McGauley G.A. affinity growth hormone binding protein in plasma of Sorensen H.A. see Schwartz P. patients with acromegaly and the effect of octreotide Stanley J.M. & Najjar S.S. Case of the Month Painful treatment 373 thyroid gland: an atypical presentation of Graves’ Rone J.K., Dons R.F. & Reed H.L. The effect of disease 468 endurance training on serum triiodothyronine kinetics Stewart P.M. see Walker B.R. in man: physical conditioning marked by enhanced Stewart P.M., Carey M.P., Graham C.T., Wright A.D. & thyroid hormone metabolism 325 London D.R. Case of the Month Growth hormone Rosenqvist M., Nordenstrém J., Andersson M. & secreting pituitary carcinoma: a case report and Edhag O.K. Cardiac conduction in patients with literature review 189 hypercalcaemia due to primary Stewart S.P. see Orme S.M. hyperparathyroidism 29 Stickland M.H. see Orme S.M. Ross R.J.M. see Miell J.P. Sun J.G. see Buckler H.M. Rosselli A.P. see Lindow S.W. Russell R.G.G. see Hassager C. Tamaki H., Katsumaru H., Amino N., Nakamoto H.., Sadeh O. see Kraiem Z. Ishikawa E. & Miyai K. Usefulness of thyroglobulin Sakati N.A. see Thakker R.V. antibody detected by ultrasensitive enzyme Salinas J.L. see Garcia-Rubi E. immunoassay: a good parameter for immune Santos M.A. see Leite V. surveillance in healthy subjects and for prediction of Saunders P.T.K., Padayachi T., Tincello D.G., Shalet post-partum thyroid dysfunction 266 S.M. & Wu F.C.W. Point mutations detected in the Tamburrano G. see Webster J. androgen receptor gene of three men with partial Tandon N. & Weetman A.P. Thyroid cells in Graves’ androgen insensitivity syndrome 214 disease and Hashimoto’s thyroiditis stimulate Scanlon M.F. see Webster J. allogeneic T cells when pretreated with phorbol Schachter D. see Gallardo E. ester 274 Schachter P.S., Christy M.D., Avigad I.S., Shabtay M. & Taylor A.M. see Miell J.P. Leight G.S. Case report Non-autonomy of Thakker R.V., Farmery M.R., Sakati N.A. & parathyroid hormone secretion in acute primary Milner R.D.G. Genetic linkage studies of X-linked hyperparathyroidism 565 hypophosphataemic rickets in a Saudi Arabian Scheithauer B.W. see O’Brien T. family 338 Schernthaner G. see Kautzky-Willer A. Thalassinos N. see Tsagarakis S. Schmidt-Gayk H. see Blind E. Theisen K. see Wehling M. Schmidt-Gayk H. see Herfarth K. Thijssen J.H.H. see Roelen C.A.M. Schwartz P., Sorensen H.A., Momsen G., McNair P. & Thomas E.J. see Eldred J.M. Transbel I. Normal pattern of parathyroid response Thompson G.R. see Baxter M.A. to blood calcium lowering in primary Thompson J. see Gregory J.W. hyperparathyroidism: a citrate clamp study 344 Thomson J.A. see Quin J.D. Scrimgeour C.M. see Gregory J.W. Thomson J.A. see Reglinski J. Sebastian J.P. see Orme S.M. Thomson J.A. see Wilson R. Serio M. see Genazzani A.D. Tincello D.G. see Saunders P.T.K. Shabtay M. see Schachter P.S. Tonacchera M. see Mariotti S. Shalet S.M. see Saunders P.T.K. Transbel I. see Schwartz P. Sheppard M.C. & Franklyn J.A. Current therapy Trimarchi F. see Cannavo S. Management of the single thyroid nodule 398 Tsagarakis S., Kontogeorgos G., Giannou P.., Sheppard M.C. see Jenkins D. Thalassinos N., Woolley J., Besser G.M. & Sheppard M.C. see Parle J.V. Grossman A. Interleukin-6, a growth promoting Sherwood R. see Miell J.P. cytokine, is present in human pituitary adenomas: an Shong M.H. see Kraiem Z. immunocytochemical study 163 582 Author index Tunbridge W.M.G. Commentary Atypical Graves’ R., Faglia G., Giordano G., Flamigni F., disease 468 Tamburrano G. & Scanlon M.F. Dose-dependent suppression of serum prolactin by cabergoline in Ulloa-Aguirre A. see Garcia-Rubi E. hyperprolactinaemia: a placebo controlled, double blind, multicentre study 534 Valcavi R., Zini M., Davoli S. & Portioli I. The late Weetman A.P. & Poole J. Failure to find an association of growth hormone rise induced by oral glucose is blood group P, with thyroid-associated enhanced by cholinergic stimulation with ophthalmopathy 423 pyridostigmine in normal subjects 360 Weetman A.P. Commentary How antithyroid drugs work Vale W. see O’Brien T. in Graves’ disease 317 Valk N.K. see Lamberts S.W.J. Weetman A.P. see Kraiem Z. Van der Lely A.J., Harris A.G. & Lamberts S.W.J. The Weetman A.P. see Tandon N. sensitivity of growth hormone secretion to medical Wehling M., Kasmayr J., Christ M., Sippell W., Theisen K. treatment in acromegalic patients: influence of age & Miiller O-A. The early mineralocorticoid effector and sex 181 mechanism, the sodium-proton exchanger, is Van der Lely A.J. see Hofland L.J. sensitized in lymphocytes from patients with Van der Spuy Z.M. see Lindow S.W. Cushing’s syndrome 260 Van Heerden J.A. see O’Brien T. Weisman Y. see Matzkin H. Van Koetsveld P.M. see Hofland L.J. Wiersinga W.M. see Adriaanse R. Vanderschueren-Lodeweyckx M. see Massa G. Wilson R. see Reglinski J. Vazquez-Aleman D. see Garcia-Rubi E. Wilson R., McKillop J.H., MacLean M., Walker J.J., von zur Miuhlen A. see Riedel M. Fraser W.D., Gray C., Dryburgh F. & Thomson J.A. Thyroid function tests are rarely abnormal in patients Waaijers M. see Hofland L.J. with severe hyperemesis gravidarum 331 Walker B.R., Campbell J.C., Fraser R., Stewart P.M. & Woolley J. see Tsagarakis S. Edwards C.R.W. Mineralocorticoid excess and Worswick L. see Clayton R.N. inhibition of 11f-hydroxysteroid dehydrogenase in Wright A.D. see Stewart P.M. patients with ectopic ACTH syndrome 483 Wu F.C.W. see Saunders P.T.K. Walker J.J. see Wilson R. Wasan H.S. & Waxman J. Current therapy Hormonal Yong E.L., Baird D.T. & Hillier S.G. Mediation of management of prostate cancer 477 gonadotrophin-stimulated growth and differentiation Wass J.A.H. see Anderson J.V. of human granuloma cells by adenosine-3’,5’- Wattie D.J. see Reid IR. monophosphate: one molecule, two messages 51 Waugh N. see Leese G.P. Young W.F. see O’Brien T. Waxman J. see Wasan H:S. Webster J., Piscitelli G., Polli A., D’Alberton A., Falsetti L.. Zieg R. see Blind E. Ferrari C., Fioretti P., Giordano G., L’Hermite M.., Zini M. see Valcavi R. Ciccarelli E., Crosignani P.G., De Cecco L., Fadini Clinical Endocrinology (1992) 37, 583-587 Subject index to Volume 37 Acromegaly GHBP and IGF-I levels in puberty 175 GH secretion and treatment; influence of age and girls with tall stature, oestrogen therapy (Commentary) sex 181 199 and GH secreting pituitary carcinoma (Case of the high SHBG in premature thelarche 203 Month) 189, 194 effect of testosterone on growth, body composition and gastritis and octreotide 227 energy in boys 207 hypothalamic or pituitary origin of pulsatile GH in 233 effect of GH on GHBP in idiopathic short stature 249 GHBP in, effect of octreotide 373 Clomiphene ACTH syndrome effect on LH in central precocious puberty 73 cortisol and 11B-OHSD (Commentary) 481, 483 Computer-assisted perimetry cAMP effectiveness in follow-up of pituitary microdenoma 157 gonadotrophin-stimulated growth and granulosa cell Coronary heart disease differentiation 51 risk in PCOS (Commentary) 117, 119 Androgen Cortisol modulation not coupled to PRL pulsatile release in and 118-OHSD in ectopic ACTH syndrome men 65 (Commentary) 481, 483 Anorexia nervosa Cushing’s disease/syndrome effects of opioid blockade and GnRH on LH in 520 pituitary histology in 254 mineralocorticoid effector mechanism, Na*-H* Blood group P, exchanger, sensitized in lymphocytes in 260 not associated with thyroidal ophthalmopathy 423 and phaeochromocytoma (Case of the Month) 460 Body composition 1,25-Dihydroxyvitamin D effect of GH on in GH deficient adults 79 in acquired vitamin D deficiency 17 effect of testosterone on in boys 207 in post-menopausal women 426 Down’s syndrome measures of in GH replacement 453 and thyroid (Review) 471 Bone density in women with multinodular goitre 35 Empty sella pyridinium cross-link excretion in HRT and and endocrine and neurological disturbances 529 menopause 45 Endurance training effects of GH on in GH deficient adults 79 and T3 metabolism 325 osteoporosis treated with hPTH and oestrogen 282 Erythrocytes post-pregnancy osteoporosis with hypercalcaemia (Case cellular metabolism and carbimazole, NMR study 319 report and review) 298 metabolism, effect of nafarelin and norethisterone 354 Fertility oncogenous osteomalacia and malignancy (Case of the and PCOS 127 Month) 379, (Commentary) 382 Fibroblasts mass in post-menopausal women 426 HLA-DR antigen expression induced by IFN-y, density and metabolism not affected by finasteride 432 glucocorticoid regulation 59 Finasteride Cabergoline does not affect bone density and metabolism 432 suppression of PRL 534 Carbimazole Gastritis and erythrocyte metabolism, NMR studies 319 and octreotide in acromegaly 227 Carbohydrate Gastrointestinal surgery effects of GH on in GH deficient adults 79 rhIGF-I after 542 Cardiac conduction Genetics with hypercalcaemia in primary hyperparathyroidism PCR in prenatal diagnosis of GH gene deletion 89 29 HLA class II gene polymorphism and Hashimoto’s Children thyroiditis 141 LH response to clomiphene in precocious puberty 73 molecular, hypogonadism and LH (Commentary) 201 583 584 Subject index mutations in androgen receptor gene in partial androgen atypical (Case of the Month) 382 insensitivity 214 Growth of X-linked hypophosphataemic rickets 338 gonadotrophin-stimulated, granulosa cell differentiation GH and cAMP 51 effect on GH deficient adults 79 oestrogen for girls with tall stature 199 use in adults (Commentary) 111 effect of testosterone on in boys 207 immunoradiometric assay and ELISA 169 GH effect on GHBP in idiopathic short stature 249 secretion in acromegaly and treatment: effect of age and sex 181 Hashimoto’s thyroiditis secreting pituitary carcinoma (Case of the Month) 189, and HLA class II gene polymorphism 141 (Commentary) 194 thyroid cells in stimulate allogeneic T cells with pulsatile in acromegaly; hypothalamic or pituitary phorbol 274 origin 233 hCG and GH mRNA following octreotide for GH-secreting and bioactivity of Pergonal 558 pituitary adenoma 240 HLA-DR antigen effect on GHBP in idiopathic short stature 249 expression in fibroblasts induced by IFN-y, rise induced by glucose enhanced by pyridostigmine 360 glucocorticoid regulation 59 deficiency syndrome in adults (Review) 387 Homeostasis replacement, measures of body composition in 453 effect of GH on in GH deficient adults 79 GH gene deletions Hormone replacement therapy PCR in prenatal diagnosis 89 menopause and excretion of pyridinium cross-links from GHBP bone 45 and IGF-I levels in puberty 175 Hypercalcaemia effect of GH on in idiopathic short stature 249 due to primary hyperparathyroidism, cardiac in acromegaly, effect of octreotide 373 conduction in 29 Glia-derived tumours of malignancy, PTHrP in 290 diagnosis and treatment | and post-pregnancy osteoporosis (Case report and Glucocorticoids review) 298 regulation of IFN-y-induced HLA-DR antigen Hyperemesis gravidarum expression in fibroblasts 59 thyroid tests in 331 GnRH Hyperprolactinaemia and opioid blockade, effect on LH in anorexia characterization of PRL in 365 nervosa 520 Hypoglycaemia GnRH agonist spontaneous, diagnosis (Review) 309 and oestrogen secreting Leydig cell tumour 221 Hypogonadism Goitre molecular genetics and LH (Commentary) 201 in women, and bone density 35 Hypotension TSH and SHBG levels in multinodular non-toxic after caused by phaeochromocytoma (Case of the radioiodine 335 Month) 304 Gonadotrophin stimulated growth, granulosa cell differentiation and cAMP 51 IFN-y Granulosa cell induced HLA-DR antigen expression in fibroblasts, differentiation, gonadotrophin-stimulated growth and regulated by glucocorticoids 59 cAMP 51 IGF-I maturity and immunoreactive inhibin after ovarian recombinant human, therapeutic potential stimulation 552 (Commentary) 11 Graves’ disease and GHBP levels in puberty 175 thyroid cells in stimulate allogeneic T cells with recombinant human, after gastrointestinal surgery 542 phorbol 274 sIL-2R antithyroid drugs in (Commentary) 317 modulation by thyroid in thyroid disease 415 erythrocytes, NMR studies of carbimazole on IL-6 metabolism 319 in pituitary adenomas: immunocytochemistry 163 Subject index 585 Immune surveillance Norethisterone thyroglobulin antibody parameter for 266 and nafarelin, effect on bone metabolism 354 Immunoglobulins thyroid-stimulating, measurement of 493 Octreotide Inhibin in acromegaly, and gastritis 227 immunoreactive during ovarian stimulation, and and GH and GH mRNA levels in GH-secreting granulosa cell maturity 552 pituitary adenoma 240 Insulin effect on GHBP in acromegaly 373 secretion, sensitivity and hepatic extraction in pHPT Oestrogen before and after surgery 147 for girls with tall stature (Commentary) 199 Iodine and hPTH in osteoporosis 282 radioactive, in multinodular non-toxic goitre, TSH and 11B-OHSD SHBG levels after 335 cortisol and ectopic ACTH syndrome (Commentary) 481, 483 Kearns-Sayre syndrome Ophthalmopathy endocrine dysfunction (Case report and review) 97 thyroidal, not associated with blood group P; 423 Opioid blockade and GnRH, effects on LH in anorexia nervosa 520 Lactation Osteomalacia PTHrP (Commentary) 402, 405 oncogenous and malignancy (Case of the Month) 379, Leydig cell tumour (Commentary) 382 oestrogen secreting, and GnRH agonist 221 Osteoporosis LH treated with hPTH and oestrogen 282 not coupled to PRL pulsatile release in men 65 post-pregnancy, and hypercalcaemia (Case report and response to clomiphene in central precocious puberty 73 review) 298 hypogonadism and molecular genetics Oxytocin (Commentary) 201 effect of morphine and naloxone on in labour 349 immunoreactive and bioactive estimates in cycle disturbances 445 Parathyroid in anorexia nervosa, effects of opioid blockade and response to blood Ca lowering in PHPT 344 GnRH on 520 Partial androgen insensitivity syndrome Lipids point mutations in androgen receptor gene in 214 effect of GH on in GH deficient adults 79 PCOS and abnormal thyroid function 411 and risk of coronary heart disease (Commentary) 117, fractions, ovarian steroids and age 437 119 and fertility 127 Men Pergonal pulsatile PRL in 65 bioactivity, and hCG 558 hormonal management of prostate cancer (Current Phaeochromocytoma therapy) 477 as cause of hypotension (Case of the Month) 304 MENI and Cushing’s disease (Case of the Month) 460 (Case of the Month) 187 Phorbol Meningiomas pretreated allogeneic T cells stimulated by thyroid cells diagnosis and treatment | in Graves’ disease and Hashimoto’s thyroiditis 274 Morphine Pituitary and naloxone, effect on OCT in labour 349 histology in Cushing’s disease 254 Pituitary adenomas Nafarelin immunocytochemistry of IL-6 in 163 and norethisterone, effect on bone metabolism 354 GH-secreting, octreotide, and GH and GH mRNA Naloxone levels 240 and morphine, effect on OCT in labour 349 Pituitary carcinoma Nelson’s syndrome GH secreting (Case of the Month) 189, (Letter) 385 (Commentary) 194 586 Subject index Pituitary microadenoma SHBG effectiveness of computer-assisted perimetry in follow- in premature thelarche 203 up 157 and TSH after radioiodine in multinodular non-toxic Polymerase chain reaction goitre 335 in prenatal diagnosis of GH gene deletions 89 Somatostatin receptor imaging Pregnancy in differential diagnosis of brain tumours | T3 determination in 41 Steroids PCR in prenatal diagnosis of GH gene deletions 89 ovarian, lipid fractions and age 437 effect of morphine and naloxone on OCT in labour 349 for thyroiditis; thyroid abscess complication (Case of Premature thelarche the Month) 570 SHBG in 203 Primary brain tumours 3 endocrine aspects of diagnosis and treatment determination in pregnancy 41 (Review) | metabolism and endurance training 325 Primary hyperparathyroidism T cells and hypercalcaemia, cardiac conduction in 29 allogeneic, with phorbol, stimulated by thyroid cells in insulin secretion, sensitivity and hepatic extraction Graves’ disease and Hashimoto’s thyroiditis 274 before and after surgery 147 Testosterone parathyroid response to blood Ca lowering in 344 effect on growth, body composition, strength and energy acute, non-autonomy of PTH secretion in (Case in boys 207 report) 565 Thionamide antithyroid drugs Primary hypothyroidism in Graves’ disease (Commentary) 317 IgG subclass distribution of TSH receptor blocking Thyroglobulin antibody antibodies in 135 for immune surveillance and prediction of post-partum circadian pulsatile TSH in 504 thyroid dysfunction 266 PRL Thyroid pulsatile release in men 65 dysfunction, thyroglobulin antibody parameter for 266 characterization in hyperprolactinaemia 365 tests in hyperemesis gravidarum 331 suppression by cabergoline 534 nodule (Current therapy) 398 Prostate cancer abnormal function and lipid circulation 411 hormonal management (Current therapy) 477 modulation of sIL-2R in thyroid disease 415 Protein -associated ophthalmopathy not associated with blood effects of GH on in GH deficient adults 79 group P, 423 PTH painful, atypical Graves’ disease (Case of the and oestrogen in osteoporosis 282 Month) 382 circadian rhythm and pulsatility of 511 and Down’s syndrome (Review) 471 non-autonomous in acute primary hyperparathyroidism abscess and thyroiditis: consequence of steroid therapy? (Case report) 565 (Case of the Month) 570 PTHrP L-Thyroxine in hypercalcaemia of malignancy 290 morbidity in normal and suppressed TSH 500 in lactation (Commentary) 402, 405 TSH Puberty and SHBG after radioiodine in multinodular non-toxic LH response to clomiphene in central precocious 73 goitre 335 GHBP and IGF-I levels in 175 circadian pulsatile in primary hypothyroidism 504 Pyridinium cross-links TSH-RBAb from bone in menopause on HRT, excretion of 45 IgG subclasses in primary hypothyroidism 135 Pyridostigmine enhances glucose-induced GH rise 360 Vitamin D deficiency 1,25-dihydroxyvitamin D in acquired 17 Rickets genetics of X-linked hypophosphataemic 338 Women with multinodular goitre, bone density in 35